738 Safety outcomes for first-in-man intradermal injections of lentiviral-engineered COL7A1-supplemented autologous fibroblasts in adults with recessive dystrophic epidermolysis bullosa: International Investigative Dermatology (IID) 2018 Meeting Abstract SupplementInternational Investigative Dermatology (IID) 2018

S.M. Lwin; F. Syed; W. Di; A. Petrova; T. Kadiyirire; J.E. Mellerio; A. Hovnanian; W. Qasim; J. McGrath

doi:10.1016/j.jid.2018.03.748

738 Safety outcomes for first-in-man intradermal injections of lentiviral-engineered COL7A1-supplemented autologous fibroblasts in adults with recessive dystrophic epidermolysis bullosa: International Investigative Dermatology (IID) 2018 Meeting Abstract SupplementInternational Investigative Dermatology (IID) 2018

S.M. Lwin, F. Syed, W. Di, A. Petrova, T. Kadiyirire, J.E. Mellerio, A. Hovnanian, W. Qasim, J. McGrath

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	S125
Journal	Journal of Investigative Dermatology
Volume	138
Issue number	5, Supplement
Early online date	19 Apr 2018
DOIs	https://doi.org/10.1016/j.jid.2018.03.748
Publication status	Published - May 2018

Access to Document

10.1016/j.jid.2018.03.748

https://www.sciencedirect.com/science/article/pii/S0022202X18309746

Cite this

Lwin, S. M., Syed, F., Di, W., Petrova, A., Kadiyirire, T., Mellerio, J. E., Hovnanian, A., Qasim, W., & McGrath, J. (2018). 738 Safety outcomes for first-in-man intradermal injections of lentiviral-engineered COL7A1-supplemented autologous fibroblasts in adults with recessive dystrophic epidermolysis bullosa: International Investigative Dermatology (IID) 2018 Meeting Abstract SupplementInternational Investigative Dermatology (IID) 2018. Journal of Investigative Dermatology, 138(5, Supplement), S125. https://doi.org/10.1016/j.jid.2018.03.748

Lwin, S.M. ; Syed, F. ; Di, W. et al. / 738 Safety outcomes for first-in-man intradermal injections of lentiviral-engineered COL7A1-supplemented autologous fibroblasts in adults with recessive dystrophic epidermolysis bullosa : International Investigative Dermatology (IID) 2018 Meeting Abstract SupplementInternational Investigative Dermatology (IID) 2018. In: Journal of Investigative Dermatology. 2018 ; Vol. 138, No. 5, Supplement. pp. S125.

@article{d603ef62c46b4cbd845a598947c3e5c5,

title = "738 Safety outcomes for first-in-man intradermal injections of lentiviral-engineered COL7A1-supplemented autologous fibroblasts in adults with recessive dystrophic epidermolysis bullosa: International Investigative Dermatology (IID) 2018 Meeting Abstract SupplementInternational Investigative Dermatology (IID) 2018",

author = "S.M. Lwin and F. Syed and W. Di and A. Petrova and T. Kadiyirire and J.E. Mellerio and A. Hovnanian and W. Qasim and J. McGrath",

year = "2018",

month = may,

doi = "10.1016/j.jid.2018.03.748",

language = "English",

volume = "138",

pages = "S125",

journal = "Journal of Investigative Dermatology",

issn = "0022-202X",

publisher = "Nature Publishing Group",

number = "5, Supplement",

}

Lwin, SM, Syed, F, Di, W, Petrova, A, Kadiyirire, T, Mellerio, JE, Hovnanian, A, Qasim, W & McGrath, J 2018, '738 Safety outcomes for first-in-man intradermal injections of lentiviral-engineered COL7A1-supplemented autologous fibroblasts in adults with recessive dystrophic epidermolysis bullosa: International Investigative Dermatology (IID) 2018 Meeting Abstract SupplementInternational Investigative Dermatology (IID) 2018', Journal of Investigative Dermatology, vol. 138, no. 5, Supplement, pp. S125. https://doi.org/10.1016/j.jid.2018.03.748

738 Safety outcomes for first-in-man intradermal injections of lentiviral-engineered COL7A1-supplemented autologous fibroblasts in adults with recessive dystrophic epidermolysis bullosa: International Investigative Dermatology (IID) 2018 Meeting Abstract SupplementInternational Investigative Dermatology (IID) 2018. / Lwin, S.M.; Syed, F.; Di, W. et al.
In: Journal of Investigative Dermatology, Vol. 138, No. 5, Supplement, 05.2018, p. S125.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - 738 Safety outcomes for first-in-man intradermal injections of lentiviral-engineered COL7A1-supplemented autologous fibroblasts in adults with recessive dystrophic epidermolysis bullosa

T2 - International Investigative Dermatology (IID) 2018 Meeting Abstract SupplementInternational Investigative Dermatology (IID) 2018

AU - Lwin, S.M.

AU - Syed, F.

AU - Di, W.

AU - Petrova, A.

AU - Kadiyirire, T.

AU - Mellerio, J.E.

AU - Hovnanian, A.

AU - Qasim, W.

AU - McGrath, J.

PY - 2018/5

Y1 - 2018/5

U2 - 10.1016/j.jid.2018.03.748

DO - 10.1016/j.jid.2018.03.748

M3 - Meeting Abstract

SN - 0022-202X

VL - 138

SP - S125

JO - Journal of Investigative Dermatology

JF - Journal of Investigative Dermatology

IS - 5, Supplement

ER -

Lwin SM, Syed F, Di W, Petrova A, Kadiyirire T, Mellerio JE et al. 738 Safety outcomes for first-in-man intradermal injections of lentiviral-engineered COL7A1-supplemented autologous fibroblasts in adults with recessive dystrophic epidermolysis bullosa: International Investigative Dermatology (IID) 2018 Meeting Abstract SupplementInternational Investigative Dermatology (IID) 2018. Journal of Investigative Dermatology. 2018 May;138(5, Supplement):S125. Epub 2018 Apr 19. doi: 10.1016/j.jid.2018.03.748